Evidence map›Paper›PMID 42310442›Full record

ReviewNature protocols2026

Solid-phase synthesis of sterically hindered peptides via ribosome-mimicking molecular reactors.

Siyuan Wei, Xuchun Zhang, Yishan Guo, Fa Liu, Zhu-Jun Yao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Siyuan Wei *State Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry, Nanjing University, Nanjing, China.
Xuchun Zhang *State Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry, Nanjing University, Nanjing, China.ORCID http://orcid.org/0009-0008-8282-1748
Yishan GuoState Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry, Nanjing University, Nanjing, China.
Fa LiuState Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry, Nanjing University, Nanjing, China. liufasioc@live.com.ORCID http://orcid.org/0000-0002-2909-9185
Zhu-Jun YaoState Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, School of Chemistry, Nanjing University, Nanjing, China. yaoz@nju.edu.cn.ORCID http://orcid.org/0000-0002-6716-4232

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22450003
6 · The paper itself

Abstract

The incorporation of N-methylated or α,α-disubstituted amino acids into peptides can markedly enhance their drug-like properties by improving proteolytic stability and membrane permeability. However, the solid-phase synthesis of such sterically hindered peptides remains a persistent challenge. Here we present a detailed protocol based on our recently developed ribosome-mimicking molecular reactor (RMMR) strategy, which substantially improves the synthetic efficiency of these difficult sequences via solid phase peptide synthesis (SPPS). This protocol provides a comprehensive, step-by-step procedure to facilitate a quick startup by the users, including the synthesis of Oxyma-C as the key activating unit precursor in the RMMR structure, the preparation of RMMR resin through modification of conventional SPPS resin and implementation of RMMR-SPPS in both manual and automated synthesizer formats. Peptides containing N-methylated and/or α,α-disubstituted amino acid(s) are synthesized efficiently using our strategy, with crude purities of up to 98% and respectable isolated yields, greatly surpassing existing methods. It is anticipated that this approach will facilitate broader adoption of RMMR-SPPS, addressing critical technical gaps and accelerating the discovery of orally bioavailable or intracellularly targeted macrocyclic peptide drug candidates.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.